MedTrace Logo

Sweat Analysis as Prognosticator After Heart Attack

NCT05843006 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 24

Last updated 2023-05-06

No results posted yet for this study

Summary

This study characterizes non-invasive body inflammation response in sweat and blood of patients suffering from acute myocardial infarction and explores the potential of non-invasive sweat analysis a an innovative approach for predicting patient outcome.

Conditions

  • Acute Myocardial Infarction

Interventions

DIAGNOSTIC_TEST

Examination and analysis of sweat and blood samples at baseline and at follow up

Subjects will be assessed at baseline (as inpatients) and at 4-6 weeks at follow-up as outpatients according to standard operating procedures. Sweat samples will be collected using the CE certified Macroduct Sweat Collector and inflammatory parameters measured. Venous blood will be drawn and inflammatory parameters, Troponin-I and nt-proBNP measured. Further examinations include measurement of left ventricular ejection fraction by echocardiography at baseline and blood pressure, heart rate, risk scores and health information will be collected at baseline and follow up.

DIAGNOSTIC_TEST

Examination and analysis of sweat and blood samples at baseline

Sweat samples will be collected using the CE certified Macroduct Sweat Collector and inflammatory parameters measured. Venous blood will be drawn and inflammatory parameters, Troponin-I and nt-proBNP measured. Blood pressure, heart rate, risk scores and health information will collected.

Sponsors & Collaborators

  • University Hospital, Basel, Switzerland

    collaborator OTHER

  • Region Örebro County

    lead OTHER

Principal Investigators

  • Ole Fröbert, MD, PhD · Department of Cardiology, Örebro University Hospital and Örebro University

Eligibility

Min Age
45 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-03-21
Primary Completion
2023-03-31
Completion
2023-03-31

Countries

  • Sweden

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05843006 on ClinicalTrials.gov